Simenepag, also known as AGN-210676, is a small molecule prostaglandin E2 receptor agonist under development for the treatment of glaucoma and ocular hypertension.
For research use only. We do not sell to patients.
| Name | Simenepag |
|---|---|
| Iupac Chemical Name | 5-((((R)-1-(4-((S)-1-hydroxyhexyl)phenyl)-5-oxopyrrolidin-2-yl)methoxy)methyl)thiophene-2-carboxylic acid |
| Synonyms | AGN-210676; AGN 210676; AGN210676; Simenepag. |
| Molecular Formula | C23H29NO5S |
| Molecular Weight | 431.547 |
| Smile | O=C(C1=CC=C(COC[C@@H](CC2)N(C3=CC=C([C@@H](O)CCCCC)C=C3)C2=O)S1)O |
| InChiKey | NGKFLYGSJDSBQC-QUCCMNQESA-N |
| InChi | InChI=1S/C23H29NO5S/c1-2-3-4-5-20(25)16-6-8-17(9-7-16)24-18(10-13-22(24)26)14-29-15-19-11-12-21(30-19)23(27)28/h6-9,11-12,18,20,25H,2-5,10,13-15H2,1H3,(H,27,28)/t18-,20+/m1/s1 |
| CAS Number | 910562-15-1 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Off-white solid to white solid |
|---|---|
| Purity | >98% |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |